Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a phase 1/2 clinical trial evaluating RZ-001 with valganciclovir in hepatocellular carcinoma; the study is active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• RZ-001
• Valganciclovir (Valganciclovir)

Snippet

Sponsor: Rznomics, Inc. | Conditions: Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING